Literature DB >> 22433954

Chk1 suppresses bypass of mitosis and tetraploidization in p53-deficient cancer cells.

Deborah Wilsker1, Jon H Chung, Fred Bunz.   

Abstract

Many cancer cells are unable to maintain a numerically stable chromosome complement. It is well established that aberrant cell division can generate progeny with increased ploidy, but the genetic factors required for maintenance of diploidy are not well understood. Using an isogenic model system derived by gene targeting, we examined the role of Chk1 in p53-proficient and -deficient cancer cells. Targeted inactivation of a single CHK1 allele in stably diploid cells caused an elevated frequency of mitotic bypass if p53 was naturally mutated or experimentally disrupted by homologous recombination. CHK1-haploinsufficient, p53-deficient cells frequently underwent sequential rounds of DNA synthesis without an intervening mitosis. These aberrant cell cycles resulted in whole-genome endoreduplication and tetraploidization. The unscheduled bypass of mitosis could be suppressed by targeted reversion of a p53 mutation or by exogenous expression of Cdk1. In contrast, the number of tetraploid cells was not increased in isogenic cell populations that harbor hypomorphic ATR mutations, suggesting that suppression of unscheduled mitotic bypass is a distinct function of Chk1. These results are consistent with a recently described role for Chk1 in promoting the expression of genes that promote cell cycle transitions and demonstrate how Chk1 might prevent tetraploidization during the cancer cell cycle.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22433954      PMCID: PMC3341228          DOI: 10.4161/cc.19944

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  45 in total

1.  Targeted inactivation of p53 in human cells does not result in aneuploidy.

Authors:  Fred Bunz; Christine Fauth; Michael R Speicher; Annie Dutriaux; John M Sedivy; Kenneth W Kinzler; Bert Vogelstein; Christoph Lengauer
Journal:  Cancer Res       Date:  2002-02-15       Impact factor: 12.701

2.  ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1.

Authors:  H Zhao; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

3.  Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions.

Authors:  Vassilis G Gorgoulis; Leandros-Vassilios F Vassiliou; Panagiotis Karakaidos; Panayotis Zacharatos; Athanassios Kotsinas; Triantafillos Liloglou; Monica Venere; Richard A Ditullio; Nikolaos G Kastrinakis; Brynn Levy; Dimitris Kletsas; Akihiro Yoneta; Meenhard Herlyn; Christos Kittas; Thanos D Halazonetis
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

4.  Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells.

Authors:  T Kanda; K F Sullivan; G M Wahl
Journal:  Curr Biol       Date:  1998-03-26       Impact factor: 10.834

5.  Checkpoint kinase 1 (CHK1) protein and mRNA expression is downregulated in aggressive variants of human lymphoid neoplasms.

Authors:  F Tort; S Hernández; S Beà; E Camacho; V Fernández; M Esteller; M F Fraga; C Burek; A Rosenwald; L Hernández; E Campo
Journal:  Leukemia       Date:  2005-01       Impact factor: 11.528

6.  Genetic instability in colorectal cancers.

Authors:  C Lengauer; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1997-04-10       Impact factor: 49.962

7.  Chk1 is haploinsufficient for multiple functions critical to tumor suppression.

Authors:  Michael H Lam; Qinghua Liu; Stephen J Elledge; Jeffrey M Rosen
Journal:  Cancer Cell       Date:  2004-07       Impact factor: 31.743

8.  Inactivation of hCDC4 can cause chromosomal instability.

Authors:  Harith Rajagopalan; Prasad V Jallepalli; Carlo Rago; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Christoph Lengauer
Journal:  Nature       Date:  2004-03-04       Impact factor: 49.962

9.  Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15.

Authors:  Y Gu; J Rosenblatt; D O Morgan
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

Review 10.  Triggering p53 after cytokinesis failure.

Authors:  P Todd Stukenberg
Journal:  J Cell Biol       Date:  2004-06-07       Impact factor: 10.539

View more
  4 in total

1.  FLJ25439, a novel cytokinesis-associated protein, induces tetraploidization and maintains chromosomal stability via enhancing expression of endoplasmic reticulum stress chaperones.

Authors:  Tai-Long Pan; Shu-Yuan Hsu; Pei-Wen Wang; Ya-Ting Cheng; Yu-Chen Chang; Sudipta Saha; Jiwei Hu; Pin Ouyang
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Pathways to chromothripsis.

Authors:  Robert Ivkov; Fred Bunz
Journal:  Cell Cycle       Date:  2015-07-15       Impact factor: 4.534

3.  Calmodulin protects Aurora B on the midbody to regulate the fidelity of cytokinesis.

Authors:  Rama K Mallampalli; Jennifer R Glasser; Tiffany A Coon; Bill B Chen
Journal:  Cell Cycle       Date:  2013-01-31       Impact factor: 4.534

4.  Immunoexpression and prognostic role of p53 in different subtypes of epithelial ovarian carcinoma.

Authors:  Lihong Chen; Lianxiang Li; Feng Chen; Dalin He
Journal:  J Biomed Res       Date:  2012-04-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.